LRRK2 and synucleinopathy: However, both LRRK2 variants accelerated the progression of a tetO-aSN transgene-mediated neuronal loss and α-synucleinopathy in CaMKII-tTA/tetO-LRRK2/tetO-aSN transgenic mice and exacerbated the accompanying astrocytosis and microgliosis.